Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016

Details for Mechanism ID: 14179
Country/Region: Cambodia
Year: 2016
Main Partner: Khmer HIV/AIDS NGO Alliance
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $4,974,841 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $495,000
Care: TB/HIV (HVTB) $100,000
Care: Pediatric Care and Support (PDCS) $50,000
Strategic Information (HVSI) $467,500
Health Systems Strengthening (OHSS) $105,000
Testing: HIV Testing and Counseling (HVCT) $1,575,000
Sexual Prevention: Other Sexual Prevention (HVOP) $440,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $50,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $50,000
Treatment: Adult Treatment (HTXS) $1,454,841
Treatment: Pediatric Treatment (PDTX) $187,500
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 6,264
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 36,905
HTS_TST Service Delivery Point (Community): Mobile testing 2017 2,664
HTS_TST Service Delivery Point (Community): Mobile testing 2017 6,653
HTS_TST Service Delivery Point (Facility): VCT 2017 30,252
HTS_TST Service Delivery Point (Facility): VCT 2017 3,600
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 72
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 516
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 98
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 551
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 10,032
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 3,493
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 75
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 366
KP_PREV By key population type: Men who have sex with men and are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 4,530
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,718
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 1,281
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 240
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 15,843
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 5,892
KP_PREV Total estimated number of key population in the catchment area 2017 36,961
KP_PREV Total estimated number of key population in the catchment area 2017 16,300
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 24,403
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 10,576
KP_PREV_den By key population type: Females who inject drugs (Female PWID) (Denominator: Total estimated number of key population in the catchment area) 2017 83
KP_PREV_den By key population type: Males who inject drugs (Male PWID) (Denominator: Total estimated number of key population in the catchment area) 2017 407
KP_PREV_den By key population type: Men who have sex with men and are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 10,958
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 4,547
KP_PREV_den By key population type: Transgender who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 1,600
KP_PREV_den By key population type: Transgender who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 687
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,524
TX_CURR Aggregated Age/Sex: 15+ Female 2017 422
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,762
TX_CURR Aggregated Age/Sex: 15+ Male 2017 575
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,286
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 997
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,286
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 997
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,286
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 997
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 494
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 51
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 526
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 57
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,020
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 108
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,020
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 108
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,829
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 798
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,574
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 762
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,695
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 353
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,879
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 409
TX_PVLS Numerator: Indication: Routine 2017 5,406
TX_PVLS Numerator: Indication: Routine 2017 739
TX_PVLS Numerator: Indication: Targeted 2017 168
TX_PVLS Numerator: Indication: Targeted 2017 23
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 176
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 186
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 45
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 30
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 63
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 421
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 108
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 468
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 120
Cross Cutting Budget Categories and Known Amounts Total: $4,216,250
Human Resources for Health $1,690,000
Key Populations: MSM and TG $1,417,500
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Key Populations: Sex Workers $708,750
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Gender: Gender Based Violence (GBV) $100,000
GBV Prevention
Implementation
Capacity building
Gender: Gender Equality $300,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation